Thursday, August 25, 2016 3:28:59 PM
Wrong, this is an online Report for brain cancer vaccine detailing information relating to medicines.
The ones in question are from the SEC form 10-K.is clearly stated.
Would you care to share where there is any mention about SEC form 10-K as you state it is clearly stated and I cannot find it anywhere.
http://www.ukmi.nhs.uk/applications/ndo/record_view_open.asp?newDrugID=4815
The comments are not "from the UK", they say nothing about what is going on in the UK.
As I said the comments are from this UK organisation that are affiliated to the UK NHS.
http://www.ukmi.nhs.uk/ukmi/about/default.asp?pageRef=1
And the date is simply when they were posted.
The date is when this particular entry was made as part of a chronological list of events relating to the treatment.
And approval over their is via the EU EMA, not NHS (though NHS would later sign off on insurance coverage once they get the EMA MMA).
This does not mean that important details about the treatment including approval would not be made to the NHS for many reasons. Also, another point on the AA or Fast track issue, below is another entry reiterating the NHS info definitely is {throughout the entire process} is gearing up to expect AA {they use your terminology in this example}
'Northwest Biotherapeutics will be able to petition the FDA for accelerated approval if the PII glioblastoma multiforme trial generates results consistent to those obtained from previous trials'
Seadogs - No battle, No victory !
Recent NWBO News
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 11/26/2025 05:15:34 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/31/2025 09:23:24 PM
FEATURED Cannabix Technologies Announces Commercial Launch of Marijuana Breath Test (MBT) • Mar 16, 2026 8:37 AM
Record Gold Prices Reshape Economics of New Mine Development • SNWGF • Mar 16, 2026 10:46 AM
Exxe Group Advances Platform Strategy and Share Structure Reduction Following Strategic Meetings • AXXA • Mar 11, 2026 1:03 PM
DRCR Pushes Forward With Implementation of 2026 Business Plan • DRCR • Mar 11, 2026 12:26 PM
Record Gold Prices Reshape Opportunities for Emerging Producers • LFLR • Mar 11, 2026 9:00 AM
C2 Blockchain Reports 803 Million DOG (Bitcoin) Holdings Following Strategic Accumulation of Bitcoin-Native Digital Assets • CBLO • Mar 10, 2026 8:00 AM
